Speaker

Frank Baas

Senior Vice President, Research, Graviton BioSciences

Frank Baas, Senior Vice President, Research at Graviton BioSciences, is speaking at 10th Complement-Based Drug Development Summit (Boston, United States of America, 8–10 Dec 2026) in the session “Identifying the Indications & Disease Stages Most Likely to Benefit from Complement-Based Therapies to Expand Scope of Treatment”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Pharmacy & Pharmaceutical Sciences

Upcoming appearances

10th Complement-Based Drug Development Summit
8–10 Dec 2026Boston, United States of America
- WorkshopIdentifying the Indications & Disease Stages Most Likely to Benefit from Complement-Based Therapies to Expand Scope of TreatmentWith Brahm Segal, Lubka Roumenina
- SpeakerTargeting the Terminal Pathway in Neurodegenerative Disease

More speakers at 10th Complement-Based Drug Development Summit

Daniel Benjamin
President & Chief Executive Officer, Cascade Biotechnology
Daniela Cipolletta
Senior Director, Immunology, Seismic Therapeutics
Thomas Ciulla
Chief Executive Officer, Ikarovec
Ron Gorham
Principal Scientist, Sanofi
Mahmud hossain
Senior Scientist, Sanofi
Viral Kansara
Chief Development Advisor, NeuParadigm Bio

See all 21 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Frank Baas, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].